(Reuters) – Use of Johnson & Johnson’s COVID-19 vaccine should be resumed in the United States as specified under its emergency use authorization by the U.S. Food and Drug Administration, advisers to the U.S. Centers for Disease Control and Prevention recommended on Friday.
(Reporting by Manas Mishra in Bengaluru and Julie Steenhuysen in Chicago)
